An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on

Amirhossein Davoodvandi1, Mahdi Rafiyan2, Zatollah Asemi2

  • 1Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran.

Insights

Long non-coding RNAs (lncRNAs) are key in gastrointestinal cancers. These molecules show promise as non-invasive biomarkers for early detection, prognosis, and guiding therapy in patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastrointestinal cancers are a leading cause of cancer death worldwide.
  • Drug resistance in cancer cells significantly contributes to high mortality rates.
  • Non-coding RNAs (ncRNAs) are increasingly recognized for their role in cancer development.

Purpose of the Study:

  • To review the role of long non-coding RNAs (lncRNAs) in gastrointestinal cancer progression.
  • To explore the potential of lncRNAs as therapeutic targets.
  • To highlight the utility of circulating ncRNAs as non-invasive biomarkers.

Main Methods:

  • Literature review focusing on lncRNAs in gastrointestinal cancers.
  • Analysis of ncRNA regulatory mechanisms (epigenetic, miRNA interactions).
  • Assessment of lncRNAs in blood for biomarker potential.

Main Results:

  • lncRNAs play critical roles in the initiation, development, and maintenance of gastrointestinal cancers.
  • lncRNAs regulate gene expression through various mechanisms, including epigenetic modifications and miRNA interactions.
  • Circulating lncRNAs are detectable in blood and show potential as non-invasive biomarkers.

Conclusions:

  • lncRNAs are crucial in gastrointestinal cancer biology and progression.
  • lncRNAs represent promising therapeutic targets for gastrointestinal cancers.
  • Circulating lncRNAs offer a novel avenue for non-invasive cancer diagnostics and prognostics.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
60
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K